Analyst Reco. Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Market Closed - Nyse Other stock markets 16:00:02 2024-04-29 EDT			5-day change	1st Jan Change
139.5 ^USD	+3.90%		+7.23%	+1.17%

04-29	US FDA publishes final rule for laboratory developed tests	RE
04-25	Labcorp beats quarterly estimates on strong testing demand	RE

Analyst Reco.

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Jefferies Adjusts Price Target on Quest Diagnostics to $160 From $155	04-24	MT
UBS Adjusts Price Target on Quest Diagnostics to $146 From $139, Maintains Neutral Rating	04-24	MT
Barclays Raises Quest Diagnostics' Price Target to $144 From $138	04-24	MT
Deutsche Bank Adjusts Quest Diagnostics Price Target to $136 From $125, Maintains Hold Rating	04-24	MT
Mizuho Adjusts Quest Diagnostics' Price Target to $155 From $150	04-24	MT
Citigroup Adjusts Quest Diagnostics Price Target to $145 From $135	04-24	MT
Leerink Partners Adjusts Quest Diagnostics Price Target to $141 From $135	04-24	MT
Truist Raises Price Target on Quest Diagnostics to $150 From $145, Cites 'Strong Start' to 2024, Keeps Hold Rating	04-24	MT
Evercore ISI Raises Quest Diagnostics Price Target to $145 from $140	04-23	MT
Leerink Partners Starts Quest Diagnostics With Market Perform Rating, $135 Price Target	02-26	MT
ANALYST RECOMMENDATIONS : Airbnb, Conagra Brands, Berkshire Hathaway, Meta Platforms, Unilever....	02-21
Jefferies Upgrades Quest Diagnostics to Buy From Hold, Adjusts Price Target to $155 From $140	02-07	MT
Fed officials fail to convince investors, who are focused on earnings	02-07
ANALYST RECOMMENDATIONS : Caterpillar, Eli Lilly, Intel, Meta, T-Mobile...	02-07
Deutsche Bank Adjusts Quest Diagnostics Price Target to $125 From $140, Maintains Hold Rating	02-02	MT
ANALYST RECOMMENDATIONS : Burberry Group, Blackrock, JPMorgan Chase, Qualcomm, Sage...	01-15
Analyst recommendations: Blackstone, Citigroup, Icon, Amazon, Broadcom...	01-03
Truist Raises Quest Diagnostics' Price Target to $150 From $145, Keeps Hold Rating	12-20	MT
BofA Securities Upgrades Quest Diagnostics to Buy From Neutral, Adjusts Price Target to $160 From $140	12-12	MT
Citigroup Adjusts Price Target on Quest Diagnostics to $145 From $130, Keeps Neutral Rating	12-11	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Analyst Reco. Quest Diagnostics Incorporated

Equities

DGX

US74834L1008

Analyst Reco.

Filters